ST. PAUL, Minn.--(BUSINESS WIRE)--Every IV catheter poses potential for serious and costly complications, including those occurring from commonly used peripheral intravenous (PIV) catheters. According ...

In the clinical trial, upon catheter removal, there were decreases noted in catheter colonization and skin colonization rates. 3M announced that the Food and Drug Administration (FDA) has approved an ...

The case for adopting the 3M Tegaderm CHG IV securement dressing for central venous and arterial catheter insertion sites is supported by the evidence. This technology allows observation, and provides ...

Significant fluid and electrolyte disturbances occur in extremely low birth weight (ELBW) infants in the first few days of life. We investigated the effect of semipermeable polyurethane membrane ...

The company did a literature search and identified 5 studies that met their selection criteria. All studies used cost–benefit analyses. Of these, 3 studies were done in the USA (Veenstra et al. 1999; ...